Royan Institute
Tehran, Iran
NCT Number: NCT01908088
Epidermolysis Bullosa (EB) is a blistering disease that is caused by defective anchoring fibrils and hemidesmosome in basement membrane of the skin layer. EB is inherited either autosomal or recessive and has 3 types. Recessive Dystrophic Epidermolysis Bullosa (RDEB) is severe with some morbidity such as mitten hand deformity.
The management of these patients is very difficult because no effective treatment has been known yet.
The EB patients with mitten hand deformity need surgery to have a biologic dressing for areas of hand which is without the skin. In this study the investigators assess the safety of autologous transplantation of cultured fibroblast on amniotic membrane (AM,as coverage) for them.
Looking for future studies?
Notify Me5 year–25 year
All sexes
Interventional
Phase 1
Tehran, Iran
Epidermolysis Bullosa patients with mitten hand deformity were included. (based on inclusion & exclusion criteria) These patients should be offered for surgery to release the adhesions between fingers and MCP. When the consent form was accepted and the lab test was confirmed, a small skin biopsy was removed from retro auricle and fibroblast cells were separated and cultured. These cells were seeded on AM and the microbial test was done as evidence to prove the safety.
Under general anesthesia, when the hands adhesion was removed, the autologous fibroblast cultured on AM was transplanted to the both hands (specially the area without skin coverage) and the hands were dressed afterward.
The dressing was changed and the wound was checked regularly to detect any complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
autologous transplantation of cultured fibroblast on amniotic membrane in patients with Epidermolysis Bullosa with mitten hands.
Other names: autologous transplantation of cultured fibroblast on amniotic membrane
Time frame: 1month
Evaluation the pain reduction 1 month after cell transplantation by VAS scoring.
Time frame: 1week
Evaluation the symptoms of any infection in the site of transplantation during 1week after transplantation.
Time frame: 1week
Evaluation the presence of any bleeding at the site of transplantation during 1 week after transplantation.
Time frame: 1month
Evaluation the healing of ulcers 1month after transplantation base on changing the dressing time.
Time frame: 3months
Evaluation the new blister or ulceration during 3 to 6 months after transplantation.
Time frame: 6months
Evaluation the range of hand motion between 0 -110 for every fingers 6 months after transplantation.
Royan Institute
Other Gov
Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane for Mitten Hand Deformity in Patients With Epidermolysis Bullosa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.